Wegovy weight loss drug - what is it, who is eligible to use it and when will it be available in UK?
manchestereveningnews.co.ukA drug which suppresses appetite will soon be available through the NHS. Semaglutide, also known as Wegovy, has been hailed a “game changer” and is reportedly popular with celebrities in the USA.
The drug, manufactured by Danish firm Novo Nordisk, is an appetite suppressant which is delivered via a weekly injection. Patients inject themselves weekly with the drug, which mimics the hormone glucagon-like peptide-1 (GLP-1) that is released after eating.
This makes people feel full, meaning they eat less and lose weight. READ MORE: Weight loss injection popular with celebrities is approved for NHS use A previous study found that people who are given the drug saw their weight drop by 12 per cent on average after 68 weeks.
Nausea and diarrhoea were the most common side effects of Semaglutide, but these were “typically transient and mild-to-moderate in severity and subsided with time, a study in the New England Journal of Medicine found.
Read more on manchestereveningnews.co.uk
